Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 


Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial

Raj Kumar, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, Amit Singh.

Abstract
Background: The burden of present pandemic of COVID-19 is increasing exponentially day by day. There is a felt need for
research on various treatment options available in the indigenous system of medicine. Ayurvedic (Indian system of medicine)
preparations have been proven previously to be effective in many viral illnesses and play an important role in boosting the
immunity of the human body.
Aim and Objectives: To evaluate the therapeutic response of ayurvedic preparation RNB on severe COVID-19 patients.
Methodology: A double-blind randomized placebo controlled clinical trial was conducted on 49 severely ill patients of COVID- 19 with one arm receiving RNB and the other placebo. Patients were evaluated on day-to-day basis and clinical improvement was assessed by a two-point reduction in patients’ admission status on a six-point ordinal scale.
Results: Statistically significant (p=0.003) difference in proportion of conversion of Real Time Polymerase Chain Reaction (RT-PCR) result after six days of intervention was observed in both groups. The mean ± SD days required for the patients to become negative by RT-PCR test was shorter in RNB compared (10.1 ± 4.1 days) versus 14.4 ± 5.9 days in control group of patients and was found to be statistically significant (p=0.012). Average days to achieve two-point improvement on “sixpoint
clinical improvement ordinal scale” was shorter in RNB group in comparison to placebo control group (7.9 ± 4.1 days versus 11.7 ± 4.7, p=0.009). The duration of hospital-stay and oxygen therapy required for management of COVID-19 cases was shorter in RNB intervention patients than in control group.
Conclusion: Immunomodulatory, anti-inflammatory, anti-viral and broncho-dilatory properties in ayurvedic formulation makes RNB an ideal drug to act as an adjuvant to standard allopathic treatment against COVID-19 illness even in severely and critically ill patients in the present scenario.

Key words: COVID-19, Ayurvedic medicine, SARS-CoV-2, RT-PCR


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Raj Kumar
Articles by Ramakant Yadav
Articles by Usha Shukla
Articles by Naresh Pal Singh
Articles by Sushil Kumar Yadav
Articles by Sushil Kumar Shukla
Articles by Manoj Kumar
Articles by Amit Singh
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. 2021; 10(3): 231-243. doi:10.5455/AAM.88853


Web Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. http://www.aamjournal.in/?mno=88853 [Access: October 19, 2021]. doi:10.5455/AAM.88853


AMA (American Medical Association) Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. 2021; 10(3): 231-243. doi:10.5455/AAM.88853



Vancouver/ICMJE Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. (2021), [cited October 19, 2021]; 10(3): 231-243. doi:10.5455/AAM.88853



Harvard Style

Kumar, R., Yadav, . R., Shukla, . U., Singh, . N. P., Yadav, . S. K., Shukla, . S. K., Kumar, . M. & Singh, . A. (2021) Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM, 10 (3), 231-243. doi:10.5455/AAM.88853



Turabian Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. 2021. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. Annals of Ayurvedic Medicine, 10 (3), 231-243. doi:10.5455/AAM.88853



Chicago Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. "Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial." Annals of Ayurvedic Medicine 10 (2021), 231-243. doi:10.5455/AAM.88853



MLA (The Modern Language Association) Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. "Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial." Annals of Ayurvedic Medicine 10.3 (2021), 231-243. Print. doi:10.5455/AAM.88853



APA (American Psychological Association) Style

Kumar, R., Yadav, . R., Shukla, . U., Singh, . N. P., Yadav, . S. K., Shukla, . S. K., Kumar, . M. & Singh, . A. (2021) Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. Annals of Ayurvedic Medicine, 10 (3), 231-243. doi:10.5455/AAM.88853








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


DOAJ

Google Scholar,

DHARA (http://www.dharaonline.org)

Ayush Research Portal (http://ayushportal.nic.in/)

Member of 

COPE ( Committee on Publication Ethics)

ICoAJE - International Committee of Ayurveda Journal Editors

Listed In

UGC-CARE list of Journals (2019)

List of Journals stating that they follow the ICMJE Recommendations ( 2017) 

.................................................................

AAM confirms its adherence with guidelines and best practices published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf) from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; (http://doaj.org/bestpractice).

.................................................................................................

The articles in Annals of Ayurvedic Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial  Share Alike License (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited and distributed with the same licence as the original .

An Official Journal of 

 

 

IASTAM member logo

Benefit Programs | SSP Society for Scholarly Publishing
 
Articles published in AAM are now being given Plum X Metrics depending upon the social media attention the articles have received. The Plum Print next to each article shows the relative activity in the categories of metrics: Captures, Mentions, Social Media and Citations. Click on the abstract of the article to see social media related attention the article has recieved .
 
Indexed by PlumX Metrics as a blog source for published research ...


ABOUT JOURNAL
POLICIES
STATEMENTS